Key result
In patients with acute heart failure, ischemic cardiomyopathy was associated with higher troponin and BNP levels and greater cardiovascular mortality (48% vs 23%, p<0.05) compared to idiopathic dilated cardiomyopathy.
Why the study?
Do biomarker levels of troponin and natriuretic peptides differ between ischemic and idiopathic dilated etiologies of severe heart failure?
Population
40 patients admitted to hospital for acute heart failure, with either ischemic or idiopathic dilated…
Design
Cohort
Follow-up
10 +/- 1 months
Authors
Loading...
May inform etiology-specific risk stratification in acute HF; leaves open whether ischemic cardiomyopathy warrants distinct management.
Cohort (n=40)
Do biomarker levels of troponin and natriuretic peptides differ between ischemic and idiopathic dilated etiologies of severe heart failure?
Absolute Event Rate: 48% vs 23%
p-value: p=<0.05
Patients with acutely decompensated heart failure due to ischemic cardiomyopathy have significantly higher levels of troponin and BNP, and higher mortality, compared to those with idiopathic dilated cardiomyopathy.
Miller et al. (2007) conducted a cohort in Acute heart failure (n=40). Ischemic cardiomyopathy vs. Idiopathic dilated cardiomyopathy was evaluated on Cardiovascular mortality (p=<0.05). In patients with acute heart failure, ischemic cardiomyopathy was associated with higher troponin and BNP levels and greater cardiovascular mortality (48% vs 23%, p<0.05) compared to idiopathic dilated cardiomyopathy.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: